Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New saliva test aims to simplify endometriosis diagnosis

NCT ID NCT06072820

Diagnosis Sponsor: ZIWIG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study was designed to check how well a new saliva test, called Endotest®, can diagnose endometriosis. Researchers planned to test the test's repeatability, how time of day affects results, and sample stability. The study was withdrawn before enrolling any participants, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Oct 2023

An estimate. Start dates often move.

Expected to finish

Jan 2024

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 43 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject aged 18 years to 43 years, * Subject having dated and signed the consent form, * Subject affiliated to the French health system, * Subject able to return for a full day for the rest of the study, * Subject whose diagnosis of endometriosis has been established with certainty or definitively ruled out. Non-Inclusion criteria: * Pregnant subject, * Subject with an acute or chronic infection (viral hepatitis, HIV...), * Subject with history of hypersensitivity or allergy, * Subject with a personal history of cancer, * Subjects with significant difficulties in reading or writing the French language, * Subject unable to comply with the study and/or follow-up procedures, * Subject who has objected to the collection of her data, * Subject participating in an interventional study or in the exclusion period of an interventional study. Exclusion Criteria: * Pregnant subject, * Subject with acute or chronic infection (viral hepatitis, HIV...), * Subject unable to comply with study and/or follow-up procedures (including absence of outside salivary sample after the inclusion visit), * Subject participating in an interventional study or in the exclusion period of an interventional study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diagnosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diagnosis Endometriosis

Contacts and locations

Locations

  • CHU de Rouen

    Rouen, Seine-Maritime, 76000, France

  • Clinique Tivoli

    Bordeaux, Gironde, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.